Bio
James Chen received his A.B. and Ph.D. degrees in Chemistry and Chemical Biology from Harvard, and he completed his postdoctoral studies at the Department of Molecular Biology and Genetics at Johns Hopkins. He joined the Stanford faculty in 2003, and his research interests span organic chemistry, chemical biology, developmental biology, and cancer biology.
The Chen lab investigates the molecular mechanisms that underlie tissue patterning and tumorigenesis, guided by chemical principles and enabled by chemical technologies. For example, the Chen group has developed small-molecule inhibitors of Hedgehog signaling, a biochemical pathway that is required for multiple aspects of embryonic development and contributes to human cancer. Among these compounds are the first specific inhibitors of cytoplasmic dyneins, microtubule motors that regulate a signaling organelle called the primary cilium. Members of the lab have also synthesized photoactivatable antisense oligonucleotides that allow gene expression to be suppressed with spatiotemporal precision. By applying these tools in zebrafish embryos, they have elucidated the transcriptional programs that regulate formation of the notochord, somites, and other mesodermal tissues.
More recently, the Chen group collaborated with the Harbury lab to devise new methods for time-resolved lanthanide microscopy. This approach takes advantage of the long-lived photoluminescence of lanthanide chelates, and it enables ultrasensitive, autofluorescence-free imaging of whole organisms. Current research interests in the lab include small-molecule modulators of stem cell metabolism, optogenetic tools for controlling developmental signaling pathways, spermiogenesis, and male contraception.
Academic Appointments
-
Professor, Chemical and Systems Biology
-
Professor, Developmental Biology
-
Professor, Chemistry
-
Member, Bio-X
-
Member, Stanford Cancer Institute
-
Faculty Fellow, Stanford ChEM-H
-
Member, Wu Tsai Neurosciences Institute
Administrative Appointments
-
Chair, Department of Chemical and Systems Biology, Stanford University School of Medicine (2016 - Present)
-
Executive Committee Member, ChEM-H Institute (2012 - Present)
-
Director, Advisory Committee for the Scholarly Concentrations Program in the Molecular Basis of Medicine (2012 - Present)
-
Faculty Director, Stanford High-Throughput Bioscience Center (2003 - Present)
-
Member, Medical Scientist Training Program Admissions Committee (2004 - Present)
-
Executive Committee Member, Stanford University School of Medicine Faculty Senate (2012 - 2016)
-
Alternate Member, Stanford University Administrative Panel on Laboratory Animal Care (2012 - 2014)
-
Departmental Representative, Stanford Biosciences Committee on Graduate Admissions and Policy (2012 - 2014)
Honors & Awards
-
Rocek Lectureship in Chemical Biology, University of Illinois at Chicago (2019)
-
NSF INSPIRE Award, NSF (2013-2017)
-
Innovation Award, Alex's Lemonade Stand Foundation (2013-2015)
-
Nature SciCafe Award for Outstanding Research Achievement, Nature Biotechnology and Nature Medicine (2009)
-
NIH Director's Pioneer Award, NIH (2008-2013)
-
American Cancer Society Research Scholar Award, American Cancer Society (2008-2011)
-
Brain Tumor Society Award, Brain Tumor Society/Rachel Molly Markoff Foundation (2006-2008)
-
Astellas USA Foundation Award, Astella USA Foundation (2005-2006)
-
Terman Fellow, Stanford University (2005-2008)
-
Basil O'Connor Starter Scholar Research Award, March of Dimes (2005-2007)
-
Kimmel Scholar Award, Sidney Kimmel Foundation for Cancer Research (2004-2006)
-
W. Barry Wood, Jr. Research Award, Johns Hopkins School of Medicine (2003)
-
American Cancer Society Postdoctoral Fellowship, American Cancer Society (2002-2003)
-
Damon Runyon-Walter Winchell Postdoctoral Fellowship, Damon Runyon Cancer Research Foundation (1999-2002)
Boards, Advisory Committees, Professional Organizations
-
Editorial Board, Zebrafish (2008 - Present)
-
Editorial Board, Cell Chemical Biology (2009 - Present)
-
Scientific Advisory Board, Vibliome Therapeutics (2019 - Present)
Professional Education
-
A.B., Harvard College, Chemistry (1991)
-
Ph.D., Harvard University, Chemistry and Chemical Biology (1998)
-
Postdoctoral Fellow, Johns Hopkins School of Medicine, Molecular Biology and Genetics (2003)
Patents
-
J. K. Chen, T. S. Kato, and A. E. Ondrus. "United States Patent 9,611,276 Imidazo bicyclic iminium compounds as antitumor agents", Leland Stanford Junior University, Apr 4, 2017
-
J.K. Chen, T.M. Kapoor, A.J. Firestone, and J. Weinger. "United States Patent 9,145,376 Quinazolinone inhibitors of dynein", The Rockefeller University, Sep 29, 2015
-
J. K. Chen, S. Sinha, I. Shestopalov, and X. Ouyang. "United States Patent 7,923,562 Photocleavable linker methods and compositions", Leland Stanford Junior University, Apr 11, 2011
-
P. A. Beachy, J. K. Chen, and A. J. N. Taipale. "United States Patent 7,655,674 Modulators of the Hedgehog signaling pathway, compositions and uses related thereto.", Johns Hopkins University, Feb 2, 2010
-
P. A. Beachy, J. K. Chen, and A. J. N. Taipale. "United States Patent 7,476,661 Regulators of the Hedgehog pathway, compositions and uses related thereto.", Johns Hopkins University, Jan 13, 2009
-
P. A. Beachy, J. K. Chen, and A. J. N. Taipale. "United States Patent 7,098,196 Regulators of the Hedgehog pathway, compositions and uses related thereto.", Johns Hopkins University, Aug 29, 2006